← Eichor
Study identifier: NCT02583061 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Toronto Gestational Glucose Tolerance Cohort

Condition: Type 2 Diabetes, Gestational Diabetes, Pre-diabetes  ·  Sponsor: Mount Sinai Hospital, Canada

PhaseN/A
Planned participants350
Who can joinFemale, 20 Years to 60 Years
Healthy volunteersYes

About this study

In this prospective observational cohort study, women representing the full spectrum of gestational glucose tolerance status are undergoing longitudinal cardiometabolic characterization at regular intervals in the years after the index pregnancy.

This description comes directly from the study's public registry record.

Talk to the study team

Ravi Retnakaran, MD  ·  416-586-4800  ·  ravi.retnakaran@sinaihealth.ca

Always discuss trial participation with your own doctor first.

Locations (1)

Mount Sinai HospitalToronto, Ontario, CanadaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT02583061